FDA Approves First Vaccine to Prevent Whooping Cough in Newborns by Giving Shot to Mother During Pregnancy
The whooping cough vaccine is the first shot the FDA has approved for use during pregnancy to prevent a disease in young infants by immunizing their mothers.Pertussis, more commonly known as whooping cough, is a highly contagious respiratory disease that can lead to serious health complications in babies.
Infants younger than two months are not old enough to receive protection through the normal childhood vaccination series. The Food and Drug Administration on Friday approved a vaccine for use in the third trimester of pregnancy to prevent whooping cough in newborn infants. The vaccine, called Boostrix, is made by GlaxoSmithKline. It is the first shot the FDA has approved for use during pregnancy to prevent a disease in young infants by the shot to their mothers, said Dr. Peter Marks, the agency's chief vaccine official.
The vaccine, which is administered as a single dose, was 78% effective in preventing whooping cough in newborns when given to mothers during the third trimester, according to data evaluated by the FDA. No side effects on the pregnancy, fetus or newborn were observed.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
The FDA is updating the definition of 'healthy' and designing new labelsThe FDA is updating the definition of healthy and designing new labels. The agency says this will help empower people to make better decisions. But not all nutrition experts are convinced.
Leer más »
Kids are flocking to flavored, disposable e-cigarettes, study findsMore than 2.5 million adolescents use the products, according to new CDC and FDA data.
Leer más »
Flavored e-cigs still used by young Americans at 'concerning' rate, FDA and CDC study showsThe study surveyed millions of middle and high school students in the U.S. about use of flavored e-cigarettes. The agencies say the responses show a cause for concern.
Leer más »
FDA approves Amylyx's much-debated drug for ALSThe FDA has approved Amylyx's highly debated drug for ALS disease based on results from a small-scale mid-stage trial.
Leer más »
Flavored e-cigs still used by young Americans at 'concerning' rate, FDA and CDC study showsThe study surveyed millions of middle and high school students in the U.S. about use of flavored e-cigarettes. The agencies say the responses show a cause for concern.
Leer más »
Flavored e-cigs still used by young Americans at 'concerning' rate, FDA and CDC study showsThe study surveyed millions of middle and high school students in the U.S. about use of flavored e-cigarettes. The agencies say the responses show a cause for concern.
Leer más »